Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover pharmacodynamic study of PSI-697 in healthy smokers
2007-005695-14Phase 2Completed
- Sponsor
- Wyeth
- Start
- Nov 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of psi-697 in atherothrombosis (2 arms), sponsored by Wyeth. Primary endpoint: Effect on platelet–monocyte aggregates. Started Nov 2007; status: completed.
02
Drugs
psi-697
03
Conditions
atherothrombosis
Beyond the preview
Go deeper on 2007-005695-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005695-14.